Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance
Seroprevalence studies have been used throughout the COVID-19 pandemic to monitor infection and immunity. These studies are often reported in peer-reviewed journals, but the academic writing and publishing process can delay reporting and thereby public health action. Seroprevalence estimates have be...
Main Authors: | Donnici, C, Ilincic, N, Cao, C, Zhang, C, Deveaux, G, Clifton, D, Buckeridge, D, Bobrovitz, N, Arora, RK |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2022
|
Similar Items
-
Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis
by: Bobrovitz, N, et al.
Published: (2021) -
SeroTracker-RoB: a decision rule-based algorithm for reproducible risk of bias assessment of seroprevalence studies
by: Bobrovitz, N, et al.
Published: (2023) -
Serology assays used in SARS-CoV-2 seroprevalence surveys worldwide: a systematic review and meta-analysis of assay features, testing algorithms, and performance
by: Ma, X, et al.
Published: (2022) -
SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
by: Lewis, HC, et al.
Published: (2022) -
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: a systematic review and meta-analysis of standardized population-based studies
by: Bergeri, I, et al.
Published: (2022)